| Literature DB >> 31351415 |
Bhupinder Kapoor1, Reena Gupta1, Monica Gulati2, Sachin Kumar Singh1, Rubiya Khursheed1, Mukta Gupta1.
Abstract
Though vesicular delivery systems have been widely explored and reviewed, no comprehensive review exists that covers their development from the inception of the concept to its culmination in the form of regulated marketed formulations. With the advancement of scientific research in the field of nanomedicine, certain category of vesicular delivery systems have successfully reached the global market. Despite extensive research and highly encouraging results in a plethora of pathological conditions in the preclinical studies, translation of these nanomedicines from laboratory to market has been very limited. Aim of this review is to describe comprehensively the various colloidal delivery systems, focusing mainly on their conventional and advanced methods of preparation, different characterization techniques and main success stories of their journey from bench to bedside of the patient. The review also touches the finer nuances of the use of modern formulation approach of DoE (Design of Experiments) in their formulation and the status of regulatory guidelines for the approval of these nanomedicines.Entities:
Keywords: Liposomes; Marketed vesicular formulations; Nanomedicine; Niosomes; Vesicular delivery
Year: 2019 PMID: 31351415 DOI: 10.1016/j.cis.2019.07.006
Source DB: PubMed Journal: Adv Colloid Interface Sci ISSN: 0001-8686 Impact factor: 12.984